Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
56
CMTL Quote, Financials, Valuation and Earnings
Last price:
$5.26
Seasonality move
:
3.97%
Day range:
$5.16 - $5.53
52-week range:
$1.19 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.31x
P/B ratio:
1.83x
Volume:
334.8K
Avg. volume:
320K
1-year change:
31.92%
Market cap:
$156.7M
Revenue:
$499.5M
EPS (TTM):
-$2.31
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Revenue | $581.7M | $486.2M | $550M | $540.4M | $499.5M | |
| Revenue Growth (YoY) | -5.68% | -16.41% | 13.11% | -1.74% | -7.56% | |
| Cost of Revenues | $388.8M | $327.8M | $386.9M | $404.4M | $393.4M | |
| Gross Profit | $192.9M | $158.4M | $163.1M | $136M | $106.2M | |
| Gross Profit Margin | 33.17% | 32.59% | 29.65% | 25.17% | 21.25% | |
| R&D Expenses | $49.1M | $52.5M | $48.6M | $24.1M | $17.4M | |
| Selling, General & Admin | $111.8M | $114.9M | $120M | $123.2M | $143.5M | |
| Other Inc / (Exp) | -$100.3M | -$23.8M | -$9.1M | -$66.2M | -- | |
| Operating Expenses | $158.2M | $161.4M | $157.8M | $134.8M | $145.3M | |
| Operating Income | $34.8M | -$3M | $5.3M | $1.2M | -$39.1M | |
| Net Interest Expenses | $6.8M | $5M | $15M | $22.2M | $45.7M | |
| EBT. Incl. Unusual Items | -$75M | -$37.1M | -$30.8M | -$100.3M | -$155.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.5M | -$4M | -$3.9M | -$295K | -$80K | |
| Net Income to Company | -$73.5M | -$33.1M | -$26.9M | -$100M | -$155.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$73.5M | -$33.1M | -$26.9M | -$100M | -$104.1M | |
| Basic EPS (Cont. Ops) | -$2.86 | -$1.63 | -$1.21 | -$4.70 | -$6.95 | |
| Diluted EPS (Cont. Ops) | -$2.86 | -$1.63 | -$1.21 | -$4.70 | -$6.95 | |
| Weighted Average Basic Share | $25.7M | $26.5M | $28M | $28.8M | $29.4M | |
| Weighted Average Diluted Share | $25.7M | $26.5M | $28M | $28.8M | $29.4M | |
| EBITDA | $65.2M | $28.7M | $38.6M | $34.5M | -$5.6M | |
| EBIT | $34.8M | -$3M | $5.3M | $1.2M | -$39.1M | |
| Revenue (Reported) | $581.7M | $486.2M | $550M | $540.4M | $499.5M | |
| Operating Income (Reported) | $34.8M | -$3M | $5.3M | $1.2M | -$39.1M | |
| Operating Income (Adjusted) | $34.8M | -$3M | $5.3M | $1.2M | -$39.1M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $116.8M | $131.1M | $151.9M | $115.8M | $111M | |
| Revenue Growth (YoY) | -13.65% | 12.32% | 15.84% | -23.77% | -4.12% | |
| Cost of Revenues | $80.4M | $89.7M | $109.3M | $107.9M | $79.3M | |
| Gross Profit | $36.4M | $41.5M | $42.6M | $7.9M | $31.7M | |
| Gross Profit Margin | 31.16% | 31.61% | 28.04% | 6.84% | 28.57% | |
| R&D Expenses | $12.5M | $12.8M | $7.8M | $3.7M | $3.8M | |
| Selling, General & Admin | $28.2M | $29.3M | $32.7M | $51.6M | $29.9M | |
| Other Inc / (Exp) | -$1.9M | -$9.1M | -- | -$88.7M | -- | |
| Operating Expenses | $40M | $40.8M | $36.8M | $37.5M | $33.3M | |
| Operating Income | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Net Interest Expenses | $1.6M | $2.2M | $4.9M | $9.5M | $11.6M | |
| EBT. Incl. Unusual Items | -$8M | -$11.7M | -$2.8M | -$146.3M | -$15.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.1M | -$608K | -$1.3M | $2.1M | $442K | |
| Net Income to Company | -$6M | -$11.1M | -$1.4M | -$148.4M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6M | -$11.1M | -$1.4M | -$97.2M | -$15.9M | |
| Basic EPS (Cont. Ops) | -$0.43 | -$0.46 | -$0.11 | -$5.29 | -$0.67 | |
| Diluted EPS (Cont. Ops) | -$0.43 | -$0.46 | -$0.11 | -$5.29 | -$0.67 | |
| Weighted Average Basic Share | $26.4M | $27.8M | $28.7M | $29.4M | $29.6M | |
| Weighted Average Diluted Share | $26.4M | $27.8M | $28.7M | $29.4M | $29.6M | |
| EBITDA | $3.9M | $8.8M | $14.1M | -$20.1M | $6.5M | |
| EBIT | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Revenue (Reported) | $116.8M | $131.1M | $151.9M | $115.8M | $111M | |
| Operating Income (Reported) | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Operating Income (Adjusted) | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $563.2M | $500.6M | $570.8M | $504.3M | $494.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $378.6M | $337.1M | $406.6M | $402.9M | $364.8M | |
| Gross Profit | $184.7M | $163.5M | $164.2M | $101.4M | $130M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $50M | $52.8M | $43.7M | $20M | $17.5M | |
| Selling, General & Admin | $112.5M | $116M | $123.4M | $142.1M | $121.8M | |
| Other Inc / (Exp) | -$11M | -$31M | -- | -$154.9M | -- | |
| Operating Expenses | $159M | $162.2M | $153.8M | $135.5M | $138.4M | |
| Operating Income | $25.7M | $1.3M | $10.4M | -$34.2M | -$8.4M | |
| Net Interest Expenses | $6.1M | $5.7M | $17.7M | $26.8M | $47.7M | |
| EBT. Incl. Unusual Items | $5.1M | -$40.7M | -$21.9M | -$243.8M | -$24.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.3M | -$2.6M | -$4.7M | $3.2M | -$1.8M | |
| Net Income to Company | $6.4M | -$38.2M | -$17.2M | -$247M | -$22.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.4M | -$38.2M | -$17.2M | -$195.8M | -$22.8M | |
| Basic EPS (Cont. Ops) | $0.05 | -$1.67 | -$0.87 | -$9.90 | -$2.31 | |
| Diluted EPS (Cont. Ops) | $0.05 | -$1.67 | -$0.87 | -$9.90 | -$2.31 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $55.5M | $33.6M | $43.9M | $327K | $23.6M | |
| EBIT | $25.7M | $1.3M | $10.4M | -$34.2M | -$8.4M | |
| Revenue (Reported) | $563.2M | $500.6M | $570.8M | $504.3M | $494.8M | |
| Operating Income (Reported) | $25.7M | $1.3M | $10.4M | -$34.2M | -$8.4M | |
| Operating Income (Adjusted) | $25.7M | $1.3M | $10.4M | -$34.2M | -$8.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $116.8M | $131.1M | $151.9M | $115.8M | $111M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $80.4M | $89.7M | $109.3M | $107.9M | $79.3M | |
| Gross Profit | $36.4M | $41.5M | $42.6M | $7.9M | $31.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $12.5M | $12.8M | $7.8M | $3.7M | $3.8M | |
| Selling, General & Admin | $28.2M | $29.3M | $32.7M | $51.6M | $29.9M | |
| Other Inc / (Exp) | -$1.9M | -$9.1M | -- | -$88.7M | -- | |
| Operating Expenses | $40M | $40.8M | $36.8M | $37.5M | $33.3M | |
| Operating Income | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Net Interest Expenses | $1.6M | $2.2M | $4.9M | $9.5M | $11.6M | |
| EBT. Incl. Unusual Items | -$8M | -$11.7M | -$2.8M | -$146.3M | -$15.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$2.1M | -$608K | -$1.3M | $2.1M | $442K | |
| Net Income to Company | -$6M | -$11.1M | -$1.4M | -$148.4M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$6M | -$11.1M | -$1.4M | -$97.2M | -$15.9M | |
| Basic EPS (Cont. Ops) | -$0.43 | -$0.46 | -$0.11 | -$5.29 | -$0.67 | |
| Diluted EPS (Cont. Ops) | -$0.43 | -$0.46 | -$0.11 | -$5.29 | -$0.67 | |
| Weighted Average Basic Share | $26.4M | $27.8M | $28.7M | $29.4M | $29.6M | |
| Weighted Average Diluted Share | $26.4M | $27.8M | $28.7M | $29.4M | $29.6M | |
| EBITDA | $3.9M | $8.8M | $14.1M | -$20.1M | $6.5M | |
| EBIT | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Revenue (Reported) | $116.8M | $131.1M | $151.9M | $115.8M | $111M | |
| Operating Income (Reported) | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Operating Income (Adjusted) | -$3.6M | $691K | $5.8M | -$29.6M | -$1.6M | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $30.9M | $21.7M | $19M | $32.4M | $40M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $158.1M | $123.7M | $163.2M | $195.6M | $144.8M | |
| Inventory | $80.4M | $96.3M | $105.8M | $93.1M | $69M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $18.2M | $21.6M | $17.5M | $15.4M | -- | |
| Total Current Assets | $287.5M | $263.3M | $305.5M | $336.6M | $270.2M | |
| Property Plant And Equipment | $79.8M | $100.1M | $97.4M | $78.9M | $74.2M | |
| Long-Term Investments | -- | -- | $3M | $824K | -- | |
| Goodwill | $347.7M | $347.7M | $347.7M | $284.2M | -- | |
| Other Intangibles | $268.7M | $247.3M | $225.9M | $194.8M | -- | |
| Other Long-Term Assets | $7.6M | $14.8M | $17.4M | $14.7M | -- | |
| Total Assets | $993.1M | $974.3M | $996.2M | $960.6M | $740.8M | |
| Accounts Payable | $36.2M | $44.6M | $64.2M | $42.5M | $26M | |
| Accrued Expenses | $74.3M | $59.4M | $56M | $56M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $4.4M | $4.1M | -- | |
| Current Portion Of Capital Lease Obligations | $8.8M | $8.7M | $8.6M | $7.9M | -- | |
| Other Current Liabilities | $15.5M | $13.4M | $12.3M | $7.3M | -- | |
| Total Current Liabilities | $203.6M | $193.5M | $212M | $183.5M | $158.2M | |
| Long-Term Debt | $240.6M | $174.4M | $201.8M | $200.7M | $239.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $492.4M | $402.5M | $445.7M | $474.3M | $446.9M | |
| Common Stock | $4.1M | $4.3M | $4.3M | $4.4M | $4.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $500.7M | $466.6M | $438.3M | $306.3M | $104.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $500.7M | $571.8M | $550.5M | $486.3M | $294M | |
| Total Liabilities and Equity | $993.1M | $974.3M | $996.2M | $960.6M | $740.8M | |
| Cash and Short Terms | $30.9M | $21.7M | $19M | $32.4M | $40M | |
| Total Debt | $240.6M | $174.4M | $206.2M | $204.8M | $243.4M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $30.9M | $21.5M | $18.1M | $29.6M | $43.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $136.8M | $128.8M | $185.1M | $180.9M | $140.3M | |
| Inventory | $87.7M | $99.7M | $85.4M | $81.8M | $67.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $18.5M | $19.5M | $20.2M | $14.2M | -- | |
| Total Current Assets | $274M | $269.6M | $353.7M | $306.6M | $266.6M | |
| Property Plant And Equipment | $87.2M | $102.3M | $87.9M | $76.3M | $76.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $347.7M | $347.7M | $333.1M | $204.6M | -- | |
| Other Intangibles | $263.4M | $242M | $220.6M | $188.2M | -- | |
| Other Long-Term Assets | $9.1M | $15.5M | $15.3M | $15.5M | -- | |
| Total Assets | $983M | $977.8M | $1B | $793.2M | $734.1M | |
| Accounts Payable | $34.4M | $42.3M | $66.5M | $43.5M | $26M | |
| Accrued Expenses | $70.5M | $62.2M | $46M | $47.2M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $206.1M | -- | |
| Current Portion Of Capital Lease Obligations | $9.2M | $8.2M | $8.2M | $7.6M | -- | |
| Other Current Liabilities | $17.7M | $13.5M | $23.7M | $9.7M | -- | |
| Total Current Liabilities | $197M | $188.8M | $390.9M | $383.3M | $156.9M | |
| Long-Term Debt | $151.7M | $193.1M | $34.6M | $28.7M | $247.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $397M | $416.6M | $461.7M | $494.1M | $455.1M | |
| Common Stock | $4.1M | $4.3M | $4.3M | $4.4M | $4.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $100M | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $586M | $561.3M | $550.8M | $299.1M | $279M | |
| Total Liabilities and Equity | $983M | $977.8M | $1B | $793.2M | $734.1M | |
| Cash and Short Terms | $30.9M | $21.5M | $18.1M | $29.6M | $43.6M | |
| Total Debt | $151.7M | $193.1M | $218.1M | $211.1M | $251.8M | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$73.5M | -$33.1M | -$26.9M | -$100M | -$155.3M | |
| Depreciation & Amoritzation | $30.4M | $31.7M | $33.3M | $33.3M | $33.5M | |
| Stock-Based Compensation | $10M | $7.8M | $10.1M | $6.1M | $3.1M | |
| Change in Accounts Receivable | -$31.2M | $33.6M | -$39.7M | -$38.3M | $33.2M | |
| Change in Inventories | -$2.3M | -$20.4M | -$14.9M | -$7.8M | $7.7M | |
| Cash From Operations | -$40.6M | $1.9M | -$4.4M | -$64.8M | -$8.3M | |
| Capital Expenditures | $16M | $19.6M | $18.3M | $13.1M | $8.6M | |
| Cash Acquisitions | $750K | -- | -- | -- | -- | |
| Cash From Investing | -$15.5M | -$19.6M | -$18.3M | $20.1M | -$8.6M | |
| Dividends Paid (Ex Special Dividend) | $10.3M | $11M | $8.7M | $268K | $158K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $51.5M | -- | -- | $157.1M | -- | |
| Long-Term Debt Repaid | -$38K | -$15K | -$1.9M | -$48.8M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.8M | -$10.3M | -$6.8M | -$18.4M | -- | |
| Cash From Financing | $39.1M | $8.6M | $20.1M | $58.1M | $24.4M | |
| Beginning Cash (CF) | $30.9M | $21.7M | $19M | $32.4M | $40M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$17M | -$9.2M | -$2.7M | $13.5M | $7.6M | |
| Ending Cash (CF) | $13.8M | $12.4M | $16.3M | $45.9M | $47.6M | |
| Levered Free Cash Flow | -$56.7M | -$17.8M | -$22.7M | -$77.9M | -$16.9M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6M | -$11.1M | -$1.4M | -$148.4M | -$15.9M | |
| Depreciation & Amoritzation | $7.6M | $8.1M | $8.3M | $9.5M | $8M | |
| Stock-Based Compensation | $921K | $904K | $2.6M | $155K | $1.1M | |
| Change in Accounts Receivable | $21.5M | -$5.3M | -$26.3M | -$2.7M | $5M | |
| Change in Inventories | -$8.5M | -$4.3M | $2.7M | -$1.2M | $973K | |
| Cash From Operations | $4.6M | -$6.2M | -$14.9M | -$24.6M | $8.1M | |
| Capital Expenditures | $3.6M | $7.2M | $3.2M | $2.4M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.6M | -$7.2M | -$3.2M | -$2.4M | -$3.3M | |
| Dividends Paid (Ex Special Dividend) | $2.9M | $3.1M | $111K | $39K | $24K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $18.7M | $19.6M | $25M | -- | |
| Long-Term Debt Repaid | -$5K | -$2K | -$625K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.4M | -$2.4M | -$2M | -$3.6M | -- | |
| Cash From Financing | -$945K | $13.3M | $17.3M | $24.2M | -$1.2M | |
| Beginning Cash (CF) | $30.9M | $21.5M | $18.1M | $29.6M | $43.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$52K | -- | -- | |
| Additions / Reductions | $56K | -$126K | -$845K | -$2.8M | $3.6M | |
| Ending Cash (CF) | $31M | $21.4M | $17.2M | $26.9M | $47.3M | |
| Levered Free Cash Flow | $1M | -$13.4M | -$18.1M | -$27M | $4.8M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.4M | -$38.2M | -$17.2M | -$247M | -$22.8M | |
| Depreciation & Amoritzation | $29.9M | $32.3M | $33.5M | $34.5M | $32.1M | |
| Stock-Based Compensation | $10.2M | $7.8M | $11.8M | $3.6M | $4.1M | |
| Change in Accounts Receivable | -$4M | $6.8M | -$60.7M | -$14.7M | $40.9M | |
| Change in Inventories | -$10.8M | -$16.2M | -$8M | -$11.6M | $9.9M | |
| Cash From Operations | $38.2M | -$9M | -$13.1M | -$74.5M | $24.3M | |
| Capital Expenditures | $18.8M | $23.2M | $14.3M | $12.3M | $9.4M | |
| Cash Acquisitions | $750K | -- | -- | -- | -- | |
| Cash From Investing | -$18.2M | -$23.2M | -$14.3M | $20.9M | -$9.4M | |
| Dividends Paid (Ex Special Dividend) | $8M | $11.2M | $5.7M | $196K | $143K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $900K | $162.5M | -- | |
| Long-Term Debt Repaid | -$43K | -$12K | -$2.5M | -$48.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.5M | -$7.3M | -$6.3M | -$20M | -- | |
| Cash From Financing | -$21.6M | $22.8M | $24M | $65M | -$950K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.6M | -$9.4M | -$3.4M | $11.5M | $14M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $19.4M | -$32.2M | -$27.4M | -$86.8M | $14.9M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$6M | -$11.1M | -$1.4M | -$148.4M | -$15.9M | |
| Depreciation & Amoritzation | $7.6M | $8.1M | $8.3M | $9.5M | $8M | |
| Stock-Based Compensation | $921K | $904K | $2.6M | $155K | $1.1M | |
| Change in Accounts Receivable | $21.5M | -$5.3M | -$26.3M | -$2.7M | $5M | |
| Change in Inventories | -$8.5M | -$4.3M | $2.7M | -$1.2M | $973K | |
| Cash From Operations | $4.6M | -$6.2M | -$14.9M | -$24.6M | $8.1M | |
| Capital Expenditures | $3.6M | $7.2M | $3.2M | $2.4M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.6M | -$7.2M | -$3.2M | -$2.4M | -$3.3M | |
| Dividends Paid (Ex Special Dividend) | $2.9M | $3.1M | $111K | $39K | $24K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $18.7M | $19.6M | $25M | -- | |
| Long-Term Debt Repaid | -$5K | -$2K | -$625K | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.4M | -$2.4M | -$2M | -$3.6M | -- | |
| Cash From Financing | -$945K | $13.3M | $17.3M | $24.2M | -$1.2M | |
| Beginning Cash (CF) | $30.9M | $21.5M | $18.1M | $29.6M | $43.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$52K | -- | -- | |
| Additions / Reductions | $56K | -$126K | -$845K | -$2.8M | $3.6M | |
| Ending Cash (CF) | $31M | $21.4M | $17.2M | $26.9M | $47.3M | |
| Levered Free Cash Flow | $1M | -$13.4M | -$18.1M | -$27M | $4.8M | |
Related Companies
Get CMTL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CMTL
Sector
P/E ratio
--
23.46x
PEG ratio
-0.01x
0.00x
P/B ratio
1.83x
2.08x
Price / LTM sales
0.31x
1.40x
Growth Metrics
CMTL
Sector
Revenue growth
-4.12%
6.61%
Earnings growth
87.38%
11.36%
Revenue (5-year growth)
-4.13%
4.89%
Earnings forecast
-$0.39
$0.15
Profitability
CMTL
Sector
Profitability FY 2025
$106.2M
$30.1M
Return on invested capital
-4.28%
-0.65%
Return on assets
-3.01%
-1.35%
Return on equity
-8.08%
0.21%
Earnings Date
Last Earnings Date
Dec
11
Next Earnings Date
Mar
10
Estimated Next Earnings Date
Mar
12
Balance Sheet
CMTL
Sector
Total cash
$43.6M
$39.2M
Short term investments
--
$16.3M
Total assets
$740.8M
$158.9M
Long term debt
$251.8M
$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
Buy
75
AXSM alert for Jan 1
Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.
Sell
50
NUTX alert for Jan 1
Nutex Health, Inc. [NUTX] is down 9.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
